2017-03-15,After Soaring to $150, Can Incyte Stir Up More Upside?
2017-02-15,Biotech Buoyed by Deal Talk
2017-02-06,ARIAD Announces Submission Of Marketing Authorization Application For Brigatinib To The European Medicines Agency
2017-01-29,The Next Target in Biotech Land
2017-01-27,The Next Target in Biotech Land
2017-01-18,Ariad Pharmaceuticals, Inc. Acquisition May Not Be In The Best Interests Of ARIA Shareholders
2017-01-14,Earnings Key to Next Week's Winners: Cramer's 'Mad Money' Recap (Friday 1/13/17)
2017-01-13,ARIAD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of ARIAD Pharmaceuticals, Inc. (ARIA) Over The Proposed Sale Of The Company To Takeda Pharmaceutical Company Limited
2017-01-12,SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ARIAD Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information
2017-01-10,4 Biotech Names That Could Be M&amp;A Targets
2017-01-09,The Merger Frenzy Is On: Here's What to Expect from the Rest of 2017
2017-01-09,These Stocks Are Too Hot, in a Bad Way : Jim Cramer's 'Mad Money' Recap
2017-01-09,Cramer: Stocks Need to Cool Down
2017-01-09,So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction
2017-01-09,The Real Apple of the Dow's Eye -- ICYMI
2017-01-09,Harwood Feffer LLP Announces Investigation Of ARIAD Pharmaceuticals, Inc.
2017-01-09,Nasdaq Separates Itself From the Rest of the Market
2017-01-09,Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference
2017-01-09,Nasdaq Hits Records Even as Crude Selloff Sours Rest of Market
2017-01-09,Facebook Makes Powerful Move Higher -- How to Trade It, Along With 6 Other Active Stocks
2017-01-09,ARIAD PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
2017-01-09,Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal
2017-01-09,Midday Report: Ariad Pharmaceuticals Jumps on Deal; Dow Takes Pause on Road to 20,000
2017-01-09,Noteworthy Monday Option Activity: ARIA, DFRG, AYI
2017-01-09,Takeda Pays $5.2 Billion for Leukemia Drug Maker Ariad, Ending Months of Takeout Speculation
2017-01-09,Dow Steps Back From 20,000 as Crude Selloff Weighs on Energy Sector
2017-01-09,Stock Picks Are Hard to Find as Small-Caps Struggle
2017-01-09,Biotech Stocks Surge Monday Amid Flurry of Deal Activity
2017-01-09,Stock Futures Mostly Lower as Crude Oil Slides Below $53
2017-01-09,ARIAD Enters Into Definitive Agreement To Be Acquired By Takeda For $5.2 Billion
2017-01-09,Takeda To Acquire ARIAD Pharmaceuticals, Inc.
2017-01-05,What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017
2017-01-03,ARIAD To Present At The 35th Annual J.P. Morgan Healthcare Conference
2017-01-03,17 Thoughts on Biotech Stocks to Kick Off 2017
2016-12-22,What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
2016-12-22,2016 Was a Terrible Year for Biotech but the Tweets Were on Point
2016-12-07,Dow Scores Another Record for Third Consecutive Day; S&amp;P 500 Also Hits New High
2016-12-07,Dow, S&amp;P 500 Trade at Session Highs in Broad Wall Street Rally
2016-12-07,S&amp;P 500 and Dow Reverse Losses to Post Intraday Records
2016-12-07,ARIAD's Investigational Medicine Brigatinib Demonstrated 15.6 Month Systemic Median Progression-Free Survival In ALTA Study
2016-12-06,ARIAD Announces Data Presentations At American Society Of Hematology Meeting
2016-12-05,ARIAD Presents Updated Brigatinib Data With 18.4 Months Median Intracranial Progression Free Survival (PFS) In ALK+ NSCLC Patients With CNS Metastases At The World Conference On Lung Cancer
2016-12-02,ARIAD To Host Webcast And Conference Call On Brigatinib Data Presentations At The World Conference On Lung Cancer
2016-11-29,ARIAD Announces FDA Full Approval And Label Update For Iclusig® (ponatinib) Based On Long-Term Efficacy And Safety Data From Phase 2 PACE Clinical Trial
2016-11-16,ARIAD Announces Data Presentations At The World Conference On Lung Cancer
2016-11-14,The Inaugural ALK+ Day Is November 15, During Lung Cancer Awareness Month. (Photo: Business Wire)
2016-11-12,'Mad Money' Lightning Round: 'Health Care Is All Over the Map'
2016-11-11,Jim Cramer's 'Mad Money' Recap: Markets Pivot From Shocked to Bullish
2016-11-09,ARIAD Announces Phase 1/2 Trial Data On Investigational Drug Brigatinib Published In The Lancet Oncology
2016-11-07,ARIAD Reports Third Quarter 2016 Financial Results
2016-11-02,Why Incyte's Shares Could Soon Hit $100
2016-11-02,ARIAD To Present At The Jefferies 2016 London Healthcare Conference
2016-11-01,ARIAD To Webcast Conference Call On Third Quarter 2016 Financial Results
2016-10-31,ARIAD Announces U.S. Food And Drug Administration Acceptance Of NDA Filing For Brigatinib
2016-10-28,SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of Ariad Pharmaceuticals Inc. And Advises Investors With Losses To Contact The Firm
2016-10-26,Pardon Me, but I Have a Few Things to Say... Vertex, Biogen, Ariad, Sarepta
2016-10-26,ARIAD Announces Publication Of The Preclinical Profile Of Brigatinib In The Journal Clinical Cancer Research
2016-10-25,Ariad Pharmaceuticals (ARIA) Stock Downgraded at JMP Securities
2016-10-25,Analysts' Actions -- Chesapeake, McCormick, Time Warner, VF Corp. and More
2016-10-24,Ariad Pharmaceuticals (ARIA) Stock Drops, JPMorgan Downgrades
2016-10-24,Analysts' Actions -- Kinder Morgan, AT&T, Verizon, 3M and More
2016-10-21,'Mad Money' Lightning Round: United and Southwest Better Than JetBlue?
2016-10-20,Jim Cramer's 'Mad Money' Recap: American Express Is Back on a Growth Track
2016-10-20,ARIAD Reaffirms Commitment To Discovering And Developing Treatments For Patients With Rare Cancers
2016-10-20,Why Ariad Pharmaceuticals (ARIA) Stock Is Sliding Today
2016-10-17,Pardon Me, but I Have a Few Things to Say... Trump, Bernie, Radius, Ariad
2016-10-17,Trader's Daily Notebook: You Might Consider Selling Facebook
2016-10-14,Why Ariad (ARIA) Stock Is Plunging Today
2016-10-14,'Mad Money' Lightning Round: I'm Faithful to Opko Health's CEO
2016-10-13,Jim Cramer's 'Mad Money' Recap: Don't Play the Short-Term Market Game
2016-10-07,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Ariad Pharmaceuticals, Inc. (ARIA)
2016-10-07,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Ariad Pharmaceuticals, Inc. - ARIA
2016-10-06,How Ariad Pharma Used a Safety Problem to Jack Up a Cancer Drug's Price
2016-09-30,Biotech Stock Mailbag: Dynavax, Puma, Ariad
2016-09-26,Ariad Pharmaceuticals (ARIA) Stock Climbs, Coverage Initiated at Leerink
2016-09-20,Ariad Pharma (ARIA) Stock Surged Today on Takeover Speculation
2016-09-19,Ariad Pharmaceuticals (ARIA) Stock Is Monday's 'Chart of the Day'
2016-09-19,Chart of the Day: Ariad
2016-08-30,ARIAD Completes Rolling Submission Of New Drug Application For Brigatinib To The U.S. Food And Drug Administration
2016-08-29,ARIAD To Present At The Morgan Stanley Global Healthcare Conference
2016-08-09,Why There Is Upside for Incyte Despite Recent Selloff
2016-08-01,PDL BioPharma Completes Second Tranche Payment Under Royalty Transaction With ARIAD Pharmaceuticals
2016-07-28,ARIAD (ARIA) Stock Pops After Q2 Beat
2016-07-28,ARIAD Reports Second Quarter And First Half 2016 Financial Results
2016-07-26,Insider Trading Alert - SKUL, EA And ARIA Traded By Insiders
2016-07-25,Bullish and Bearish Reversals for the Week
2016-07-21,These 5 Stocks Under $10 Are Set to Soar Higher
2016-07-20,Barbarian At The Gate: ARIAD Pharmaceuticals (ARIA)
2016-07-05,ARIAD To Webcast Conference Call On Second Quarter 2016 Financial Results
2016-06-24,ARIAD Announces Webcast Of Its Annual Stockholders Meeting
2016-06-20,ARIAD Pharmaceuticals (ARIA) Marked As A Dead Cat Bounce Stock
2016-06-17,ARIAD Completes Strategic Review And Announces Plans For Growth
2016-06-17,ARIAD Announces Distribution Agreements For Iclusig® In Latin America And The Middle East/North Africa
2016-06-17,ARIAD Initiates Submission Of New Drug Application For Brigatinib To The U.S. Food And Drug Administration Ahead Of Plan
2016-06-13,ARIAD Announces Long-Term Safety And Efficacy Data Of Ponatinib From Phase 2 Pace Clinical Trial
2016-06-08,ARIAD To Host Analyst & Investor Day In New York City
2016-06-07,Today's Weak On High Volume Stock: ARIAD Pharmaceuticals (ARIA)
2016-06-06,Cancer Drug Stocks: The Winners and Losers From ASCO 2016
2016-06-06,ARIAD's Investigational Medicine Brigatinib Demonstrates 54 Percent Confirmed Objective Response Rate And 12.9-Month Median Progression-Free Survival In ALTA Study
2016-06-04,ARIAD Presents Data From Mutational Profiling In Crizotinib-Resistant Patients Treated With Investigational Medicine Brigatinib Showing Similar Response Rates In Patients With And Without Secondary ALK Mutations
2016-06-04,ARIAD Presents Long-Term Phase 1/2 Trial Follow Up On Investigational Drug Brigatinib With Median Time On Treatment Of 17 Months In ALK+ NSCLC Patients
2016-06-02,Trade-Ideas: ARIAD Pharmaceuticals (ARIA) Is Today's Post-Market Leader Stock
2016-06-02,ARIAD Completes The Sale Of Its European Operations And Out-License Of European Rights To Iclusig®
2016-06-01,ARIAD To Present At The Jefferies 2016 Global Healthcare Conference
2016-05-31,Ariad Pharmaceuticals Is Nearly Done Building Base Pattern
2016-05-31,Trade-Ideas: ARIAD Pharmaceuticals (ARIA) Is Today's Strong On High Relative Volume Stock
2016-05-31,ARIAD Announces Initiation Of Phase 1/2 Clinical Trial Of AP32788, An Investigational Oral Inhibitor Of EGFR And HER2, In Patients With Non-Small Cell Lung Cancer
2016-05-26,Insider Trading Alert - DEPO, ARIA And ROG Traded By Insiders
2016-05-24,ARIAD Announces Appointment Of Jennifer L. Herron As Chief Commercial Officer
2016-05-19,ARIAD Announces Pricing And Reimbursement For Iclusig In France
2016-05-18,ARIAD Announces Data Presentations At The 2016 ASCO Annual Meeting
2016-05-10,Biotech Gets a Lifeline
2016-05-10,ARIAD Reports First Quarter 2016 Financial Results And Progress On Strategic Review
2016-05-09,Incyte Buys European Business Hub From Ariad Pharma
2016-04-27,Trade-Ideas: ARIAD Pharmaceuticals (ARIA) Is Today's Weak On High Relative Volume Stock
2016-04-26,Insider Trading Alert - DWRE, ARIA And PTC Traded By Insiders
2016-04-26,ARIAD To Webcast Conference Call On First Quarter 2016 Financial Results
2016-04-19,ARIAD Announces Results Of Preclinical Studies On AP32788 At The Annual Meeting Of The American Association For Cancer Research
2016-04-15,ARIAD Presents Updated Phase 1/2 Clinical Data On Brigatinib In Patients With ALK+ Non-Small Cell Lung Cancer
2016-04-11,ARIAD Announces Initiation Of Randomized, First-Line Phase 3 Trial Of Brigatinib In Treatment Of ALK-Positive Non-Small Cell Lung Cancer
2016-03-29,ARIAD Announces Reduction In Workforce As Part Of Ongoing Company-Wide Strategic Review
2016-03-22,ARIAD Reports Inducement Grant To New Chief Financial Officer
2016-03-11,Manmeet S. Soni (Photo: Business Wire)
2016-02-29,ARIAD To Present At Upcoming Investor Conferences
2016-02-24,First Week of April 15th Options Trading For ARIAD Pharmaceuticals (ARIA)
2016-02-23,ARIAD Reports 2015 Financial Results, Provides 2016 Product Revenue Guidance And Outlines Company Progress
2016-02-10,ARIAD To Present At The RBC Capital Markets Healthcare Conference
2016-02-04,Insider Trading Alert - AEP, JBSS And ARIA Traded By Insiders
2016-02-02,ARIAD To Webcast Conference Call On Fourth Quarter And Year-End 2015 Financial Results
2016-02-01,AP32788 (gray) Shown Binding To EGFR (Photo: Business Wire)
2016-01-19,ARIAD Pharmaceuticals (ARIA) Stock Gets ‘Underweight’ Rating at Barclays
2016-01-15,ARIAD Reports Inducement Grant To New Chief Executive Officer
2016-01-13,Perilous Reversal Watch: ARIAD Pharmaceuticals (ARIA)
2016-01-12,Trade-Ideas: ARIAD Pharmaceuticals (ARIA) Is Today's Strong On High Relative Volume Stock
2016-01-11,ARIAD Announces Termination Of Shareholder Rights Plan
2016-01-10,Alexander J. Denner, Ph.D (Photo: Business Wire)
2016-01-08,ARIAD And Otsuka Submit New Drug Application In Japan For Ponatinib
2016-01-07,Relative Strength Alert For ARIAD Pharmaceuticals
2015-12-18,Paris Panayiotopoulos, President And Chief Executive Officer Of ARIAD Pharmaceuticals, Inc., Effective January 1, 2016. (Photo: Business Wire).
2015-12-11,ARIAD Announces Pricing And Reimbursement Negotiations For Iclusig In France To Continue Into 2016
2015-12-07,ARIAD Announces Initiation Of OPTIC-2L Randomized Phase 3 Trial Of Ponatinib Vs. Nilotinib In Second-Line Patients With Chronic-Phase Chronic Myeloid Leukemia
2015-11-25,Interesting ARIA Put Options For January 2016
2015-11-05,ARIAD Announces Iclusig Data Presentations At Annual American Society Of Hematology Meeting
2015-11-03,ARIAD Reports Third Quarter 2015 Financial Results And Progress On Strategic Objectives
2015-10-27,ARIAD To Webcast Conference Call On Third Quarter 2015 Financial Results
2015-10-21,First Week of December 18th Options Trading For ARIAD Pharmaceuticals (ARIA)
2015-10-12,ARIA January 2018 Options Begin Trading
2015-09-30,ARIAD Pharmaceuticals (ARIA) Showing Signs Of A Dead Cat Bounce Today
2015-09-23,First Week of ARIA May 2016 Options Trading
2015-09-15,ARIAD Announces Full Enrollment In Phase 2 ALTA Trial Of Brigatinib
2015-09-14,Tetraphase Executive Profits Hours Before Stock Plummets
2015-09-04,Insider Trading Alert - SABR, DLTR And ARIA Traded By Insiders
2015-09-03,Interesting ARIA Put And Call Options For October 23rd
2015-09-03,Today's Dead Cat Bounce Stock Is ARIAD Pharmaceuticals (ARIA)
2015-09-02,Market News: Biogen, Vera Bradley, Ariad Pharmaceuticals
2015-08-31,3 High-Volume Stocks to Trade Now (or Not)
2015-08-31,Perilous Reversal Stock: ARIAD Pharmaceuticals (ARIA)
2015-08-28,Barbarian At The Gate: ARIAD Pharmaceuticals (ARIA)
2015-08-21,ARIAD Pharmaceuticals (ARIA) Marked As A Dead Cat Bounce Stock
2015-08-14,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of Ariad Pharmaceuticals Inc. -- ARIA
2015-08-10,ARIAD Announces First Patient Treated In Phase 2 Dose-Ranging Optic Trial Of Iclusig (Ponatinib)
2015-08-05,ARIAD Reports Second Quarter 2015 Financial Results And Progress On Strategic Objectives
2015-07-29,Perilous Reversal Watch: ARIAD Pharmaceuticals (ARIA)
2015-07-29,ARIAD To Receive Up To $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing With PDL BioPharma
2015-07-29,PDL BioPharma Completes Royalty Transaction With ARIAD Pharmaceuticals
2015-07-28,ARIAD Pharmaceuticals (ARIA) Flagged As Strong On High Volume
2015-07-22,ARIAD To Webcast Conference Call On Second Quarter 2015 Financial Results
2015-06-29,ARIAD Pharmaceuticals Is Now Oversold (ARIA)
2015-06-29,ARIA: Insiders Vs. Shorts
2015-06-23,First Week Of February 2016 Options Trading For ARIAD Pharmaceuticals (ARIA)
2015-06-12,ARIAD Announces Long-Term Safety And Efficacy Data Of Ponatinib From Phase 2 Pace Clinical Trial
2015-06-10,ARIAD And Paladin Announce Commercial Distribution Agreement For Iclusig (Ponatinib) In Canada
2015-06-08,ARIAD To Present At The Goldman Sachs Annual Global Healthcare Conference
2015-06-01,ARIAD Presents Updated Clinical Data On Brigatinib In Patients With ALK+ Non-Small Cell Lung Cancer At The 2015 ASCO Meeting
2015-05-31,ARIAD Announces Long-Term Safety And Efficacy Data Of Ponatinib In Chronic-Phase Chronic Myeloid Leukemia From Phase 1 Clinical Trial
2015-05-21,ARIAD To Present At The Jefferies 2015 Global Healthcare Conference
2015-05-14,ARIAD Announces Data Presentations At The 2015 ASCO Annual Meeting
2015-05-07,ARIAD Reports First Quarter 2015 Financial Results And Progress On Strategic Objectives
2015-05-06,ARIAD Announces Commercial Distribution Agreement For Iclusig (ponatinib) In Turkey
2015-04-29,Strong On High Volume: ARIAD Pharmaceuticals (ARIA)
